Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state

Title:

Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state
Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state

Creator:

Maniyozova, Gulnoza, Negmatshaeva, Habiba, Yuldasheva, Ozoda, Turaeva, Gulnoza, and Parpieva, Dilfura

Contributor:

Maniyozova, Gulnoza, Negmatshaeva, Habiba, Yuldasheva, Ozoda, Turaeva, Gulnoza, and Parpieva, Dilfura

Identifier:

https://cdk.lib.cas.cz/client/handle/uuid:bmc15010747-5750f793-2254-4074-9cf9-cf4f369d4008
uuid:bmc15010747-5750f793-2254-4074-9cf9-cf4f369d4008
local:bmc15010747
http://ojs.journals.cz/index.php/EMHPJ/issue/archive
isrc: xxx
local: bmc15010747

Subject:

antifosfolipidový syndrom--etiologie--farmakoterapie--krev, potrat spontánní--prevence a kontrola, komplikace těhotenství--prevence a kontrola, fibrinolytika--terapeutické užití, antiflogistika--terapeutické užití, enzymová terapie--metody--statistika a číselné údaje, antioxidancia--terapeutické užití, hemostáza--účinky léků, kohortové studie, ženské pohlaví, lidé, těhotenství, výsledek terapie, and Serrata

Type:

model:article, article, Text, hodnotící studie, and TEXT

Format:

electronic, electronic resource, remote, and elektronický zdroj

Description:

Background: Obstetric complications developing at antiphospholipid syndrome are serious medical-social problem. Seeking of the treatment methods sets conditions for urgency of the article reviewed. Enzyme preparations are widely applied for treatment of women with fecundity disorder and hemorheology changes. Research objective was in clinico-laboratorial evaluation of Serrata drug impact in antiphospholipid syndrome in women with reproductive losses of Andijan state. Methods: Data of 43 women in the non-pregnancy state with reproductive losses (RL) in past history with revealed APS had been studied by us. Results: Thus, conducted therapy with Serrata was conductive to haemostasis. Conducted researches confirm the safety of application., Gulnoza Maniyozova, Habiba Negmatshaeva, Ozoda Yuldasheva, Gulnoza Turaeva, Dilfura Parpieva, and Literatura

Language:

English

Rights:

http://creativecommons.org/publicdomain/mark/1.0/
policy:public

Relation:

European medical, health and pharmaceutical journal--MED00177703

Source:

European medical, health and pharmaceutical journal : open access reviewed journal | 2014 Volume:7 | Number:2

Harvested from:

CDK

Metadata only:

false

Date:

2014